First Time Loading...

Create Medic Co Ltd
TSE:5187

Watchlist Manager
Create Medic Co Ltd Logo
Create Medic Co Ltd
TSE:5187
Watchlist
Price: 985 JPY -2.09% Market Closed
Updated: Apr 28, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

19.3B
+0.5%
Assets
Growth Rates:
1 Year
+2%
3 Years
+13%
5 Years
+12%
7 Years
+9%
10 Years
+10%
4.3B
+3%
Liabilities
Growth Rates:
1 Year
+4%
3 Years
+12%
5 Years
-1%
7 Years
-14%
10 Years
-15%
14.9B
-0.3%
Equity
Growth Rates:
1 Year
+1%
3 Years
+13%
5 Years
+16%
7 Years
+19%
10 Years
+21%

Balance Sheet Decomposition
Create Medic Co Ltd

19.3B
Assets
4.3B
Liabilities
19.3B
Assets
4.3B
Liabilities
Current Assets 12.7B
Cash & Short-Term Investments 4.4B
Receivables 3.4B
Other Current Assets 4.9B
Non-Current Assets 6.5B
Long-Term Investments 454.3m
PP&E 5.4B
Intangibles 565.7m
Other Non-Current Assets 126.5m
Current Liabilities 3B
Accounts Payable 787.6m
Accrued Liabilities 68.2m
Short-Term Debt 800m
Other Current Liabilities 1.3B
Non-Current Liabilities 1.3B
Other Non-Current Liabilities 1.3B

Balance Sheet
Create Medic Co Ltd

Rotate your device to view
Balance Sheet
Currency: JPY
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
4 363
4 130
4 839
4 623
4 281
4 331
3 973
4 359
4 306
4 393
Cash Equivalents
4 363
4 130
4 839
4 623
4 281
4 331
3 973
4 359
4 306
4 393
Short-Term Investments
500
100
200
0
0
0
0
0
0
0
Total Receivables
3 576
3 557
3 625
3 450
3 440
3 403
3 375
3 552
3 518
3 424
Accounts Receivables
3 576
3 557
3 625
3 450
3 440
3 403
3 375
3 552
3 275
3 253
Other Receivables
0
0
0
0
0
0
0
0
243
171
Inventory
2 650
2 568
2 449
2 680
2 977
3 025
3 105
3 218
3 849
4 314
Other Current Assets
332
353
320
373
338
371
270
445
457
592
Total Current Assets
11 422
10 709
11 433
11 126
11 036
11 129
10 723
11 575
12 129
12 723
PP&E Net
5 179
5 571
5 451
5 295
5 266
5 153
4 990
5 080
5 163
5 389
Intangible Assets
219
206
211
221
215
234
437
687
637
566
Long-Term Investments
643
565
302
338
250
260
550
394
548
454
Other Long-Term Assets
444
141
215
279
471
381
398
340
389
126
Total Assets
17 907
N/A
17 191
-4%
17 612
+2%
17 259
-2%
17 238
0%
17 158
0%
17 097
0%
18 076
+6%
18 866
+4%
19 259
+2%
Liabilities
Accounts Payable
865
875
1 087
833
798
673
764
684
807
788
Accrued Liabilities
43
43
59
55
54
64
67
74
115
68
Short-Term Debt
900
900
900
900
900
900
800
800
800
800
Current Portion of Long-Term Debt
447
241
333
413
166
179
105
15
26
0
Other Current Liabilities
752
659
915
853
996
837
847
1 000
1 070
1 311
Total Current Liabilities
3 007
2 719
3 294
3 053
2 914
2 652
2 583
2 573
2 817
2 967
Long-Term Debt
603
562
691
275
259
118
14
0
108
0
Deferred Income Tax
0
0
0
0
0
0
0
0
0
216
Other Liabilities
1 399
768
1 022
1 063
1 179
1 212
1 273
1 282
1 217
1 131
Total Liabilities
5 009
N/A
4 048
-19%
5 008
+24%
4 391
-12%
4 352
-1%
3 983
-8%
3 869
-3%
3 855
0%
4 142
+7%
4 314
+4%
Equity
Common Stock
1 462
1 462
1 462
1 462
1 462
1 462
1 462
1 462
1 462
1 462
Retained Earnings
8 887
9 248
9 433
9 575
9 921
10 292
10 607
10 931
10 871
10 586
Additional Paid In Capital
1 486
1 486
1 486
1 486
1 486
1 486
1 486
1 486
1 486
1 486
Unrealized Security Profit/Loss
79
103
61
86
24
30
12
25
56
77
Treasury Stock
35
35
291
291
291
291
514
514
510
506
Other Equity
1 018
880
453
551
284
196
174
830
1 359
1 839
Total Equity
12 897
N/A
13 143
+2%
12 604
-4%
12 868
+2%
12 886
+0%
13 175
+2%
13 228
+0%
14 220
+8%
14 724
+4%
14 944
+1%
Total Liabilities & Equity
17 907
N/A
17 191
-4%
17 612
+2%
17 259
-2%
17 238
0%
17 158
0%
17 097
0%
18 076
+6%
18 866
+4%
19 259
+2%
Shares Outstanding
Common Shares Outstanding
10
10
9
9
9
9
9
9
9
9

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 132,100+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.